Allarity Therapeutics (ALLR) EBIT Margin (2020 - 2026)
Allarity Therapeutics' EBIT Margin was -10752.00% in Q1 2026.
Powered by 
Analysis
Allarity Therapeutics (ALLR) EBIT Margin (2020 - 2026) Analysis & Trends
For FY2025, EBIT Margin at Allarity Therapeutics came in at -3939.06%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.40 Bn | 1,140.99 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 642.90 Bn | 561.42 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 375.88 Bn | 330.26 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 302.81 Bn | 266.80 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 268.58 Bn | 242.27 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 242.38 Bn | 197.78 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.63 Bn | 167.83 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 28.37% |
| 10 | Allarity Therapeutics | 13.68 Mn | -54.69 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -10,752.00% |
| Sep 30, 2021 | -14,192.86% |
| Sep 30, 2020 | -786.43% |
API Access
Allarity Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALLR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ALLR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALLR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();